🔎 Trials Near Me

Hjem › Melanom › Ohio › Columbus

Melanom kliniske forsøg i Columbus, OH

21 studier for Melanom søger deltagere på steder i og omkring Columbus (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Mount Carmel East Hospital, Columbus
  • The Mark H Zangmeister Center, Columbus
  • og 8 flere
Alder 40 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT05334069

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

RekruttererFase 3
  • The Ohio State University Wexner Medical Center, Columbus
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06246916

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

RekruttererFase 3
  • Ohio State University, Columbus
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT05727904

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

RekruttererFase 3
  • Ohio State University Comprehensive Cancer Center, Columbus
Alder 75 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT07068074

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

RekruttererFase 1
  • Ohio State University, Columbus
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT06529822

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

RekruttererFase 2
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Mount Carmel East Hospital, Columbus
  • Columbus Oncology and Hematology Associates Inc, Columbus
  • og 15 flere
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT04511013

Project: Every Child for Younger Patients With Cancer

RekruttererObservationsstudie
  • Nationwide Children's Hospital, Columbus
  • Ohio State University Comprehensive Cancer Center, Columbus
Op til 25 år · Alle køn · Opdateret 25. aug. 2026 · NCT02402244

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

RekruttererFase 1/2
  • The Ohio State University Comprehensive Cancer Center, Columbus
Alder 18 og opefter · Alle køn · Opdateret 11. aug. 2026 · NCT05592626

Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma

RekruttererFase 1
  • Ohio State University Comprehensive Cancer Center, Columbus
Alder 18 til 99 · Alle køn · Opdateret 13. jul. 2026 · NCT04697576

Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain

RekruttererFase 1/2
  • Ohio State University Comprehensive Cancer Center, Columbus
Alder 18 og opefter · Alle køn · Opdateret 11. jun. 2026 · NCT05588453

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

RekruttererFase 1/2
  • Ohio State University Wexner Medical Center Gynecologic Oncology at Mill Run, Columbus
Alder 18 og opefter · Alle køn · Opdateret 13. maj 2026 · NCT03686124

Neoadjuvant Darovasertib in Primary Uveal Melanoma

RekruttererFase 3
  • Ohio State Eye and Ear Institute, Columbus
Alder 18 og opefter · Alle køn · Opdateret 6. maj 2026 · NCT07015190

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

RekruttererObservationsstudie
  • Memorial Hospital, Marysville · 27 mi væk
Alder 18 og opefter · Alle køn · Opdateret 17. mar. 2026 · NCT06418204

EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers

RekruttererFase 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Alder 18 til 99 · Alle køn · Opdateret 10. mar. 2026 · NCT06223659

Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome

RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
  • The Ohio State University Wexner Medical Center, Columbus
Alle aldre · Alle køn · Opdateret 9. mar. 2026 · NCT04792463

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

RekruttererFase 3
  • The Ohio State University Comprehensive Cancer Center, Columbus
Alder 18 og opefter · Alle køn · Opdateret 25. feb. 2026 · NCT05549297

A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma

RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
  • Ohio State University Comprehensive Cancer Center, Columbus
Alle aldre · Alle køn · Opdateret 17. feb. 2026 · NCT04567706

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

RekruttererFase 3
  • Ohio State University Wexner Medical Center, Columbus
Alder 18 og opefter · Alle køn · Opdateret 17. dec. 2025 · NCT03567889

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RekruttererObservationsstudie
  • Massive Bio SYNERGY-AI site, Columbus
Alle aldre · Alle køn · Opdateret 28. okt. 2025 · NCT03452774

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Rekrutterer
  • Ohio State University Comprehensive Cancer Center, Columbus
Alder 18 og opefter · Alle køn · Opdateret 27. nov. 2024 · NCT03860883

Melanom forsøg i andre byer

Andre studier i Columbus

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.